Europe - FRA:56S1 - FR0013154002 - Common Stock
We assign a fundamental rating of 5 out of 10 to 56S1. 56S1 was compared to 20 industry peers in the Life Sciences Tools & Services industry. Both the profitability and the financial health of 56S1 get a neutral evaluation. Nothing too spectacular is happening here. 56S1 shows excellent growth, but is valued quite expensive already. These ratings could make 56S1 a good candidate for growth investing.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 2.71% | ||
ROE | 5.63% | ||
ROIC | 4.6% |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | 14.71% | ||
PM (TTM) | 7.78% | ||
GM | 44.63% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.71 | ||
Debt/FCF | 5.98 | ||
Altman-Z | 3.96 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 1.91 | ||
Quick Ratio | 1.18 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 47.26 | ||
Fwd PE | 36.37 |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | 38.27 | ||
EV/EBITDA | 28.69 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | 0.36% |
FRA:56S1 (10/3/2025, 7:00:00 PM)
195.2
+5 (+2.63%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | 0.36% |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 47.26 | ||
Fwd PE | 36.37 | ||
P/S | 6.56 | ||
P/FCF | 38.27 | ||
P/OCF | 24.11 | ||
P/B | 4.75 | ||
P/tB | N/A | ||
EV/EBITDA | 28.69 |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 2.71% | ||
ROE | 5.63% | ||
ROCE | 5.78% | ||
ROIC | 4.6% | ||
ROICexc | 5.12% | ||
ROICexgc | 15.67% | ||
OM | 14.71% | ||
PM (TTM) | 7.78% | ||
GM | 44.63% | ||
FCFM | 17.14% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.71 | ||
Debt/FCF | 5.98 | ||
Debt/EBITDA | 3.84 | ||
Cap/Depr | 93.43% | ||
Cap/Sales | 10.07% | ||
Interest Coverage | 2.82 | ||
Cash Conversion | 106.77% | ||
Profit Quality | 220.28% | ||
Current Ratio | 1.91 | ||
Quick Ratio | 1.18 | ||
Altman-Z | 3.96 |